chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Narrative: The patient received two doses of Pfizer COVID 19 vaccine in Jan/Feb 2021 and a booster dose per ED note. The patient tested positive on 5 Jan 2022 and was admitted to the hospital with cough, chills, malaise, hypoxia, and bradycardia. The patient was treated with dexamethasone and oxygen. The patient is still hospitalized as of 10 Jan 22.
Head had strange feelings as something traversing throughout the blood vessels. This sensation persisted for 3 days.  I knew to expect my arm to hurt for several days, but pain persisted for 5 weeks.
Client reported to Health Unit Oct. 10, 2012, reported, "I received a Flu shot here on Oct 4, 2012 to my right arm and yesterday Oct. 9, 2012, I began experiencing, chest discomfort with breathing/dry cough/sore throat/multiple blistered red raised areas with severe itching and swelling to and around injection site". Cortisone ointment applied to site/throat lozenges given/cold compress given for self application. Referred to Primary Health Care Team for further evaluation.
This spontaneous report was received from a 80 year old male consumer with high cholesterol, arthritis, high blood pressure and blocked coronary artery and no known drug reactions/allergies who three years ago, in approximately January 2010 was vaccinated with a dose of live ZOSTAVAX subcutaneous under the skin. No other co-suspects were reported. Concomitant medications included ZOCOR, COZAAR, baby aspirin and unspecified vitamins (OTC). The consumer reported that in December 2012, 3 years after receiving live ZOSTAVAX he was diagnosed with shingles that were affected his facial area severely. He also stated he believed she was now developing Post herpetic (PHN). On an unknown date, a barium ultrasound and an EEG were performed (results not provided). The patient was given FAMVIR 500 mg- 3 pills for 7 days as treatment for the events. The outcome  of shingles and PHN was unknown. The relatedness for shingles and PHN was unknown for live ZOSTAVAX. Additional information has been requested.
Patient said I wanted to let you know that I'm having an experience similar to someone I know though my mobility limitations aren't quiet as severe. My shoulder has been sore and painful since the FLUZONE vaccine on 10/24/2008. I saw my primary care physician yesterday and she said it's either an inflammation from the shot or that the shot hit a tendon. She prescribed an anti-inflammatory drug and if that doesn't help then I'll need to see an orthopedist.
Patient is a 34 yo now G3P2011 (EDC 5/7/21) who presented at 4/23/21 for routine prenatal visit with 38w0d fetal demise noted after 24-48hrs of low abdominal cramping. Male fetus weighing 3820gm (approximately 80th centile) without obvious dysmorphic features. The couple declined autopsy.
received influenza vaccine 9/14/2009 @1200 L deltoid . developed redness, tenderness , itching at site within 24 hours. Symptoms subsiding at time of evaluation 9/16/2009 @ 1400, with rednesss 4cm x 2.5 cm no induration. mild itching no pain recommended warm compresses. po benadryl for itching otc prn every 6 hours
Approximately 5-6 hours post vax, pt started breaking out with hives. Benadryl 50mg given every 4 hours with no improvement by 11/26/2000. Pt went to ER, medication given 11/28/2000, not much improvement. Pt returned to physician.
difficulty swallowing; This case was reported by a physician via sales rep and described the occurrence of swallowing difficult in a 18-year-old male patient who received Men B NVS (Bexsero) (batch number ABX657AA, expiry date unknown) for prophylaxis.   On 15th February 2019, the patient received the 1st dose of Bexsero. On 27th February 2019, 12 days after receiving Bexsero, the patient experienced swallowing difficult. On an unknown date, the outcome of the swallowing difficult was unknown.   It was unknown if the reporter considered the swallowing difficult to be related to Bexsero.  Additional details were provided as follows: The patient experienced difficulty swallowing.  The physician concerned that patient said food was getting stuck in patient's throat. Testing was done and report came back that it was low percentage of environmental. The reporter was agreed to follow up.      Lab Comments: On an unknown date in 2019, the patient underwent testing and the report showed that it was low percentage of environmental.
Information has been received from a registered nurse concerning a 7 year old female pt who on 01/22/1998 was vaccinated int he left deltoid with the first dose of varicella virus vaccine live. There was no concomitant medication. On 01/03/2001 the pt's mother called the physician's office and reported that the pt developed chicken pox. The event was also referred to as breakthrough varicella. The pt did not seek medical attention and no prescription drug treatment was required. Subsequently, the pt recovered. No further info is available.
It really hit me like a wave. I wasn't sick and then all of sudden I felt really strange. We came home and I was ok but the next day I had chills, fever, and brain fog which lasted for a day. I emailed my doctor and they called me after I had taken a home test that was negative. I went to take a PCR test as requested by the doctor. It was positive so the doctor prescribed Paxlovid. I was extremely tired throughout this process. Today is the best that I have felt. I do believe that I have completely recovered.
Received HiB #4, PREVNAR #4, Varicella #1 and MMR #1 on 02/14/11 / on 02-24-11 pt. had a rash - (see attached note).
Purple mark around injection site . Directly below the site, there is a large red patch that is swollen and warm to the touch.  I had a red patch and swelling after the first dose also. That one is now a faint purple.  Same arm.
extremely dizzy & nauseated; became dizzy Friday AM; nausea started Saturday afternoon; Today 12OCT93  feels much better;
she had her period and non stop bleeding for 21 days with no end in sight; shaking; dizziness; nausea; sick; dry heaving; headache; Every muscle felt that I did a total body work out; Low grade fever of 96.8; weakness; loose stools; Slept 5-6 post inoculation/slept most of the day; tiredness; This is a spontaneous report from a contactable consumer (patient). A 27-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in the right arm on 12Mar2021 08:30 (Batch/Lot number was not reported) as 1ST DOSE, SINGLE, for covid-19 immunization.  Medical history included concussion from Sep2019. The patient received birth control within 2 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient hasn't been tested for COVID-19. Patient slept 5-6 post inoculation. On 12Mar2021 03:15, patient experienced loose stools. On Saturday morning 13Mar2021 at 3am, patient woke to shaking, dizziness, nausea, so much so that she did get sick twice, dry heaving followed for the next three hours. Extreme constant headache during the day and slept most of the day. She tried her best to stay hydrated. Every muscle felt that she did a total body work out, works than she had experienced with the flu. She had a low grade fever of 96.8. Continued weakness, tiredness, and headache Monday and Tuesday. It was also reported that on 13Mar2021 at 04:00 she had her period and non stop bleeding for 21 days with no end in sight. The outcome of event "she had her period and non stop bleeding for 21 days with no end in sight" was not recovered. The outcome of all other events was reported as Recovered/Resolved with Sequel. The patient did not receive treatment for the events.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
"Staff member presented to clinic to inform of probable reaction to COVID-19 Vaccine.  Has generalizes red, raised, itchy rash to her body...nurse observed rash area to exposed skin areas of neck and arms.  Denies any SOB/dyspnea/throat or tongue swelling. States rash has been present for about 5 days. States has history of delayed rash response to various meds and vaccines where she needs to take Benadryl and sometimes steroids. Has been completed CDC daily questionnaire since about day 4 post vaccination."
body swelling legs, stomach, arms; itching; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (body swelling legs, stomach, arms) and PRURITUS (itching) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Apr-2021, the patient experienced SWELLING (body swelling legs, stomach, arms) and PRURITUS (itching). At the time of the report, SWELLING (body swelling legs, stomach, arms) and PRURITUS (itching) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported Patient was consulted by a nurse to take piedmont as treatment.,No prescriptions written.
myalgia, neck pain with motion, global headache visual disturbance, difficulty with focusing on objects, dark spots in front of eyes, difficulty with thoughts: forming/completing thoughts, extreme fatigue, fever and chills. fever to 100 degree. all treated with rest, hydration, tylenol, resolved by 0900 on 11/19/2019
COUGH/COLD SYMPTOMS/RUNNY NOSE; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported and batch number: 206A21A expiry: 07/AUG/2021) dose was not reported, administered on 12-APR-2021 to Left Arm for prophylactic vaccination. No concomitant medications were reported.  On 13-APR-2021, the subject experienced cough/cold symptoms/runny nose. Treatment medications (dates unspecified) included: chlorphenamine maleate/ibuprofen/phenylephrine hydrochloride, and guaifenesin. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from cough/cold symptoms/runny nose on APR-2021. This report was non-serious.
had a bad reaction to urinating blood; This is a spontaneous report from a contactable consumer (patient) received via a Pfizer sponsored program.    A female patient of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number was not reported), via an unspecified route of administration on 25May2021 as dose 1, single for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced had a bad reaction to urinating blood on an unspecified date in 2021. She had not received the second dose yet. She wanted to know if it was safe for her to start all over again to take the first dose or should she proceed to get the second dose. The outcome of the event was unknown.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Sore arm; Two doses of the Comirnaty 18 days apart/Inappropriate schedule of Vaccine administered; This is a spontaneous report received from a contactable reporter(s) (Pharmacist) from medical information team.  A 71-year-old female patient received bnt162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), in Oct2023 as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: comirnaty (2023-2024 formula) (DOSE 1, SINGLE), administration date: 22Sep2023, for Covid-19 Immunization, reaction(s): "sore arm". The following information was reported: INCORRECT DOSE ADMINISTERED (non-serious) with onset Oct2023, outcome "unknown", described as "Two doses of the Comirnaty 18 days apart/Inappropriate schedule of Vaccine administered"; PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "Sore arm".  Additional information: Patient got two doses of the Comirnaty 18 days apart. The first one on 22Sep2023. She mentioned, She had not have any side effects other than a sore arm.  The information on the batch/lot number for bnt162b2 omi xbb.1.5 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300324833 same reporter/patient/product, different dose/AE;
Crying - non stop - for over 6 hours 1 1/2 days after vaccine. Seen at children's medical center. No physical findings.
Tingling sensation started in lower legs, moved up through body to arms and head, lips. Tongue felt swollen. Radial pulse rapid 100. BP 94/70. Benadryl liquid 4 tsps po with relief in 10 minutes.
Child stated felt weak post vaccination, states hit head on handrail on stairs, no bleeding, redness noted B/P taken by school nurse 110/70 P 80. Will notify Pt MD if need. States grandmother. Grandmother came to pick up child. Mother called stated no previous reaction to vaccination.
This case was reported by a consumer via call center representative and described the occurrence of prickly heat in a 65-year-old female patient who received SHINGRIX for prophylaxis. Co-suspect products included Flu Seasonal QIV Dresden for prophylaxis and Hepatitis B vaccine for prophylaxis. On 20th April 2018, the patient received the 1st dose of SHINGRIX (intramuscular) .5 ml, Influenza vaccine 2017-2018 season and Hepatitis B vaccine. On 23rd April 2018, 3 days after receiving SHINGRIX, Influenza vaccine 2017-2018 season and Hepatitis B vaccine, the patient experienced prickly heat, fever, chills, extensive swelling of vaccinated limb, injection site discoloration, pain in arm, burning skin and itchy rash. On an unknown date, the outcome of the prickly heat, burning skin and itchy rash were not recovered/not resolved and the outcome of the fever, chills, extensive swelling of vaccinated limb, injection site discoloration and pain in arm were recovered/resolved. The reporter considered the prickly heat, fever, chills, extensive swelling of vaccinated limb and pain in arm to be related to SHINGRIX. It was unknown if the reporter considered the injection site discoloration, burning skin and itchy rash to be related to SHINGRIX. It was unknown if the reporter considered the prickly heat, fever and chills to be related to Influenza vaccine 2017-2018 season and Hepatitis B vaccine. Additional details were provided as follows: The patient received flu shot or hepatitis B in the right arm. The patient received the SHINGRIX in left arm. The patient had a prickly rash appear 3 days after the vaccination. The patient also had the other side effects of fever, chills, swelling of her arm from her elbow to her shoulder, big round bulls eye at the site of the injection and her arm was very sore these all had resolved. The first case of the prickly rash which she described as very painful, felt like a burn and was itchy and resolved, but the rash reappeared past Thursday before the time of reporting. The patient was given either the flu shot or Hepatitis B shot in the right arm on the same date but she could not remember which. The patient was constantly being vaccinated due to the nature of her job but she had not experienced this effects before.
Patient felt fatigue, malaise, SOB and chest pain 2-4 days after vaccine
I started feeling bad and I knew I was getting bronchitis. I was coughing, body aches, headaches. I was unable to get to the doctor because of the holiday and weather. Once I finally got into the doctor I was diagnosed with bronchitis. I was given a nebulizer and inhaler to help with my breathing and an antibiotic. I started to feel better but within a week I started to feel worse. The original symptoms were a lot worse, the coughing was very productive with mucus, the headaches were very intense, the body aches were horrible. I took a home COVID-19 test that came back negative. I went back to the doctor they did not test me for COVID-19 or Influenza A and B. I was given NEXIUM to help with my upset stomach and ADVAIR to help with my breathing. It has taken until the first week of March of this year for me to feel better. I do still have some brain fog.
This spontaneous social media report was received from the patient's parent via other company notification from Pfizer (manufacturer control number 2016578699) and refers to a currently 18 year old male patient. The patient's concurrent conditions, medical history and concomitant therapy were not reported. On an unspecified date, in early January 2015, the patient was vaccinated with a dose of  GARDASIL (dose, route of administration, lot # and expiration date were not reported). Other suspect therapies included meningococcal vaccine (unspecified) (reported as T104 - FB - Meet Meningitis), which was administered on the same day (dose, indication and route of administration were not reported).  On an unspecified date in 2015 (within a few weeks), the patient started suffering from strange aches and pains and sinus troubles. One month later, on an unknown date in 2015, the otherwise healthy teen, was hospitalized and nearly died from a rare autoimmune disease that attacked his lungs, joints, kidneys and eyes. The patient's parent reported that the patient would live with that disease for the rest of his life.  The outcome of the events of strange aches and pains and sinus troubles was not reported. The outcome of the event of rare autoimmune disease was not recovered. The relatedness between the adverse events and  GARDASIL and meningococcal vaccine (unspecified) was not reported. The event of rare autoimmune disease was considered to be life threatening by the reporter. Upon internal review, the event of rare autoimmune disease was determined to be medically significant.  Additional information has been requested.
31May90 pt vax;  devel maculopapular eruption.  09Jun90 exp febrile convulsion.  Dx of viral syndrome & reaction vax considered.
Severe rash on left forearm lasting 3 days at this point, still present. Rash on right bicep below injection site. Rash behind left knee. Small rash above right knee. Swollen around eyes, puffy skin underneath. No other events have transpired since rash appearance to explain its occurrence. No change in diet or exposure to plants/animals. No previously known allergies.
shingles; do hurt; This case was reported by a consumer via interactive digital media and described the occurrence of shingles in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced shingles and pain. On an unknown date, the outcome of the shingles and pain were unknown.   It was unknown if the reporter considered the shingles and pain to be related to Shingles vaccine.  Additional case details were reported as follows: The case was reported by patient. The age at vaccination was not reported. The patient had Shingles shot and broke out with shingles and they also hurt. The patient would not take the 2nd shot. No contact details were reported.
I started to break out in hives mainly on my arms lower an forearm my face my neck and on my chest then it increased to my legs an the back of my neck
This spontaneous report was received from an approximately 62 year old female consumer who was reporting on herself. The patient's medical history and concurrent conditions were not reported. The patient reported that she had drug reactions to pain killers which upset her stomach and many of them caused her hair fail out, including ibuprofen, ketoprofen or made her vomit, including codeine. In October 2014 (exact date not provided), the patient was vaccinated with a single dose of ZOSTAVAX, subcutaneous, lot # J01335, dose 0.65 ml, (injection site and expiration date were not reported). Concomitant therapies included simvastatin (manufacturer unknown). On 27-MAR-2015, the patient developed a "shingles-like rash and blisters". The patient stated that the rash and blisters were "very, very painful, red, and her skin felt like it was burning. Anything that touched her skin, it hurt". The patient sought medical attention via seeing an unspecified nurse. No lab diagnostic studies were performed. No treatment was given for the adverse events due to the patient's reaction to pain killers. The outcome of the events was reported as not recovered at the time of the report. Relatedness between the events and ZOSTAVAX was not reported. The patient believed that the batch she received "was defective" and requested a lot check. Additional information is not expected, because the patient did not give permission to contact her physician for further information.
No adverse Reactions Reported. In November 2022 our Immunization  program did our every-other-year audits in Both our offices.  It was discovered at that time, that some Covid Vaccines were administered outside of the 10 week expiration date (which is calculated from the date the vaccines were received from the State.) The program directed us to fill out forms and send them to you. The state also counselled us that it was our providers + parents joint decision as to whether to re-vaccinate pts or not.  We only use Pfizer vaccines for Covid- and the listed lot #'s given outside the expiration date are listed below.  FM0698 (orange top) FM0698 (purple top) FL8095 (orange top) FL8094 (orange top) FM7552 (purple) FM0698 (purple) FP4554 (purple) FL8094 (orange) FL8095 (orange) FT1551 (orange) Please see the attached forms, and feel free to contact the office for further questions or concerns.
First experienced heart racing, fatigue, dizziness and heaviness in your legs followed by hives that moved throughout the body including face, hairline, ears, legs, arms for the next 2.5 days.
achy up until this morning; weak; slight temperature increase, from 96 degrees Fahrenheit normally to 99.2 degrees Fahrenheit; soreness in the arm; headaches; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (achy up until this morning), ASTHENIA (weak), PYREXIA (slight temperature increase, from 96 degrees Fahrenheit normally to 99.2 degrees Fahrenheit), MYALGIA (soreness in the arm) and HEADACHE (headaches) in an 81-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 010M20A and 012L20A) for COVID-19 vaccination.     Concurrent medical conditions included Factor V deficiency (clotting factor deficiency). Concomitant products included METFORMIN, LOSARTAN, LEVOTHYROXINE, SIMVASTATIN and ACETYLSALICYLIC ACID (BABY ASPIRIN) for an unknown indication.   On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN (achy up until this morning), ASTHENIA (weak), PYREXIA (slight temperature increase, from 96 degrees Fahrenheit normally to 99.2 degrees Fahrenheit) and HEADACHE (headaches). an unknown date, the patient experienced MYALGIA (soreness in the arm). At the time of the report, PAIN (achy up until this morning), ASTHENIA (weak), PYREXIA (slight temperature increase, from 96 degrees Fahrenheit normally to 99.2 degrees Fahrenheit), MYALGIA (soreness in the arm) and HEADACHE (headaches) outcome was unknown.            No treatment information was reported.  Patient received third dose on 16-AUG-2021, Lot #: 066D21A.   This case was linked to MOD-2021-290147 (Patient Link).